CSI Market
Sign In | Register

Artelo Biosciences Inc (ARTL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ARTL Annual Balance Sheets →
Balance sheet data covering Artelo Biosciences Inc–Jun 30 2025 offers a view into how Jun 30 2026's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & Short-term Investments0.00
Other Current Assets4.20
Prepaid Expense And Other Assets Current0.17
Total Current Assets4.37
Intangible Assets2.04
Other Assets, Noncurrent0.05
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents10.27
Operating Lease Right Of Use Asset0.06
Total Assets6.46
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.30
Accrued Liabilities, Current AC0.00
Derivative Liability, Current DE0.00
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current0.15
Total Current Liabilities1.46
Convertible Notes Payable NO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.01
OperatingLeaseLiabilityNoncurrent0.02
Due To Related Parties0.47
Operating Lease Liability Current0.04
Total Liabilities1.46
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock73.64
Retained Earnings / Accumulated Deficit-68.40
Accumulated Other Comprehensive Income-0.24
Other Equity-0.24
Common Stockholder's Equity5.00
Total Stockholder's Equity5.00
Liabilities & Stockholder's Equity6.46
4 historic quarters locked

Sign in to unlock the full Artelo Biosciences Inc balance sheet history.

Sign In Create Free Account

About Artelo Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 12, 2026
  • Source: artl_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640334-26-001323

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.